Skip to content
Open access

Genotype‐Dependent Functional and Pharmacological Profiling of Rare GCK Variants Reveals Implications for Precision Management of Monogenic Diabetes

Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 11821 - 11827 · 0 citations · 28 references
Medicine

Abstract

Rare GCK variants contribute to heterogeneous forms of monogenic diabetes, yet the molecular basis underlying their diverse functional consequences and pharmacological responsiveness remains incompletely understood. As glucokinase (GCK) serves as a central glucose sensor in pancreatic β‐cells and hepatocytes, defining the functional properties of individual variants may improve molecular diagnosis and inform the interpretation of potential therapeutic responses in GCK‐maturity‐onset diabetes of the young (GCK‐MODY, also called MODY2).

Read PDF

Similar papers

Review Open access Oct 2026

Multifaceted role of genetic and epigenetic architecture of glucose homeostasis and diabetes

Glucose homeostasis depends on coordinated genetic and epigenetic regulation of pancreatic beta-cells, insulin-sensitive tissues, and neuroendocrine circuits. This review synthesises evidence from over 600 GWAS loci and the primary literature published between 2008 and 2026, and emerging single-cell functional genomics...

Manoj Khokhar · 0 citations
Open access Oct 2026

From Fingerprint to Function: A Convergent Framework for Translational Metabolomics in Autoimmune Disease

Autoimmune diseases are clinically heterogeneous, and patients who share a diagnosis often diverge in outcome and drug response, yet conventional biomarkers capture only part of this variation. This feature article explores how metabolomics, the molecular readout closest to the phenotype, can strengthen precision medic...

Amarkant Kumar · 0 citations
Review Open access Oct 2026

Towards precision medicine in diabetes: pharmacogenomic approaches for MODY and type 2 diabetes with insights from GLIS3 gene variants

This review evaluates pharmacogenomic evidence across monogenic and polygenic diabetes subtypes, presents Indian clinical case studies demonstrating the consequences of genomic misclassification, and positions GLIS3 as an underexplored regulatory gene with cross-disease relevance spanning neonatal diabetes, Type 1, and...

A. Lenin, Jasmin Sajini Rajayan · 0 citations
Review Oct 2026

Inherited Platelet Disorders and Use of Genetic Testing.

Inherited platelet disorders (IPDs) are caused by pathogenic variants in genes responsible for megakaryocyte and platelet biology, leading to qualitative and quantitative platelet defects. Advances in high-throughput sequencing plus variant-curation expertise and detailed clinical evaluation have led to the identificat...

I. Eldem, J. Di Paola · 0 citations
Review Open access Oct 2026

Current translational perspectives for diagnosis and individualized therapy in rare genetic diseases

Rare diseases affect hundreds of millions of individuals worldwide, primarily resulting from genetic factors, with many presenting during childhood. Advances in genome sequencing increasingly enable identification of the responsible gene in more patients; however, only a limited selection of therapies exists to correct...

S. Niazi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.